Navigation Links
Alfacell Provides ONCONASE(R) NDA Submission Update
Date:12/5/2008

utical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. For more information, visit www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainty whether the clinical trial results will allow the company to complete submission of a New Drug Application and if a New Drug Application submission is completed, uncertainty whether FDA will file or approve such application, uncertainties involved in transitioning from concept to product, uncertainties involving the ability of the company to finance research and development activities, potential challenges to or violations of patents, uncertainties regarding the outcome of clinical trials or differences of opinion in interpreting the results of clinical trials, the company's ability to secure necessary approvals from regulatory agencies, dependence upon third-party vendors, and other risks discussed in the company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the company undertakes no obligation to update these statements for revisions or changes after the date of this release.

    Media Contact:                      Investor Contact:
    David Schull or Wendy La
'/>"/>
SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
2. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
3. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
4. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
5. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
6. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
7. Alfacell Corporation to Present at UBS Global Life Sciences Conference
8. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. Sangamo BioSciences Provides Update on Companys 2008 Progress and 2009 Objectives
11. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General ... AMGN ) announced today that they ... and validate new therapeutic targets and develop novel ... disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... CHARLOTTESVILLE, Va. , May 28 The Focused Ultrasound Surgery ... the 2nd International Symposium on MR-guided Focused Ultrasound and can be accessed ... , , ... near Dulles International Airport, Washington, DC , the symposium ...
... ProUroCare Medical, Inc. (OTC Bulletin Board: PUMD, PUMDU and PUMDW), ... will be attending the American Urological Association (AUA) 2010 Annual ... – June 1 . At the conference, the ... to educate urologists about the concept and potential of elasticity ...
Cached Medicine Technology:Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound 2Abstract Submissions and Registration Now Open for 2nd International Symposium on MR-Guided Focused Ultrasound 3ProUroCare to Showcase Investigational Portable Platform for Its Prostate Imaging Device at AUA 2010 2
(Date:4/17/2014)... non-cancerous prostate tissue may have nearly twice the risk ... inflammation, according to results of a new study led ... , The link between persistent inflammation and cancer was ... those with a Gleason score between 7 and ... and rapidly growing prostate cancers. , "What we,ve shown ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... 2014) Doctors who treat patients with a ... can face an agonizing treatment decision. , The ... and help relieve shortness of breath. But some ... can cause potentially fatal complications following transplantation. , ... Dilling, medical director of Loyola University Medical Center,s ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... - Avoid Select Vitamins, Try Acupuncture, NORTHBROOK, ... American College of Chest Physicians (ACCP) recommend,against the ... general,screening of lung cancer. Published as a supplement ... of the ACCP, the guidelines cite there,is little ...
... Ohio, Sept. 10 AtriCure, Inc.,(Nasdaq: ATRC ... and selling innovative cardiac surgical devices, announced,today that ... implanted during an open-heart surgical procedure performed by,Professor ... University of Zurich,in Switzerland with the support of ...
... think they have a vaginal yeast infection are wrong ... treating their problem, says a Saint Louis University researcher ... isnt a yeast infection, said Susan Hoffstetter, Ph.D., assistant ... Louis University School of Medicine and a SLUCare womens ...
... Sept. 10 Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) ... officer, will provide an update on,the progress of Sangamo,s ... business strategy at 1:30 pm (PT) on Monday,September 17, ... San Francisco. The presentation will be webcast live ...
... A vascular surgery technique pioneered at UT Southwestern ... thigh to repair the aorta does not create blood-flow ... patients, researchers report. , Vascular disease is a major ... of the aorta. Inserting synthetic grafts to repair damaged ...
... could fight cancer, heart disease, researchers say , , MONDAY, Sept. ... life, a new European study suggests. , "The intake ... from any cause of death," said lead researcher Dr. Philippe ... Lyon, France. , The new finding, published in the Sept. ...
Cached Medicine News:Health News:New Lung Cancer Guidelines Oppose General CT Screening 2Health News:New Lung Cancer Guidelines Oppose General CT Screening 3Health News:New Lung Cancer Guidelines Oppose General CT Screening 4Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 2Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 3Health News:AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System 4Health News:Common misdiagnosis: most women believe they have a yeast infection when they don't 2Health News:Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference 2Health News:Natural aorta grafts have few side effects for infection-prone patients 2Health News:Vitamin D Supplements May Lengthen Life 2
... developed a range of Milli-Q ultrapure ... water quality requirements. Each of the ... to specifically target contaminants detrimental to ... biology and ICP-MS. The systems incorporate ...
... Millipore has developed a range ... to match specific water quality requirements. ... systems is designed to specifically target ... as HPLC, molecular biology and ICP-MS. ...
... Bridge assembly allows internal or ... cooling coil allows rapid cool-down ... within approximately 10 C of ... is only 5.7 inches wideideal ...
Inquire...
Medicine Products: